Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,736 public trials 631 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Evaluation of the Efficacy of Respicure® (Resveratrol / Quercetin) in the Management of Respiratory Conditions Including Asthma,COPD and Long COVID.

NCT05601180

Conditions
Asthma, Bronchial Diseases, COVID-19, +27 more
Locations
  • CHU Beni Messous/Pneumologie A Algiers, Algeria
  • CHU Beni Messous/Pneumologie B Algiers, Algeria
  • CHU Annaba/Pneumo-phtisiologie Annaba, Algeria
  • EPH Batna/Pneumo-phtisiologie Batna City, Algeria
View Trial Details
Completed

A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT03738397

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Clinical Research Center AL /ID# 210277 Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences /ID# 211688 Little Rock, Arkansas, United States
  • Tien Q Nguyen MD, Inc /ID# 208934 Fountain Valley, California, United States
  • UCSF Fresno /ID# 213253 Fresno, California, United States
View all 159 locations
View Trial Details
Completed

Undiagnosed COPD and Asthma Population Study (UCAP)

NCT03148210

Conditions
Asthma, Bronchial Diseases, COPD, +12 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • University of Alberta Edmonton, Alberta, Canada
  • Vancouver General Hospital- The Lung Centre Vancouver, British Columbia, Canada
  • St. Boniface General Hospital Winnipeg, Manitoba, Canada
View all 15 locations
View Trial Details
Completed

Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma

NCT05104892

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Investigational Site Number : 0320004 Berazategui, Buenos Aires, Argentina
  • Investigational Site Number : 0320006 CABA, Buenos Aires, Argentina
  • Investigational Site Number : 0320003 CABA, Buenos Aires, Argentina
  • Investigational Site Number : 0320001 Buenos Aires, Argentina
View all 51 locations
View Trial Details

Related conditions